Blog – Apathy Research: Why Should We Bother?
Rebecca WilliamsDid you know, Apathy affects over 90% of people with behavioural variant frontotemporal dementia? Rebecca Williams discusses the topic and her research.
Science
Improving animal models for the study of Alzheimer’s
UK DRIThe UK DRI hosted a presentation from Dr Michael Sasner discussing recent advances in efforts to generate translationally-relevant mouse models of Alzheimer’s.
Is Alzheimer’s an Autoimmune Disease?
Alz ForumHere’s a tau twist that may take some adapting to. CD4+ and CD8+ T cells, may be responsible for the neurodegeneration seen in Alzheimer’s and other tauopathies
Building an ‘atlas’ of the Alzheimer’s brain
Hear about UK Dementia Research Institute work on ‘Building an ‘atlas’ of the Alzheimer’s brain’ with Dr Johanna Jackson
Taking vitamin D could help prevent dementia
Dementia ResearcherTaking vitamin D supplements may help ward off dementia, according to a new, large-scale study from University of Calgary & University of Exeter.
Professor Michal Schwartz, Weizmann Institute of Science Seminar
Catch-up on this lecture delivered by Professor Michal Schwartz – Immunotherapy to defeat Alzheimer’s disease: A transformative understanding of brain immunity
Blog – Stem Cells
Dr Yvonne CouchStem Cells, or specifically induced pluripotent stem cells. what they are, why people use them & what’s their use in dementia research, Dr Yvonne Couch explores
What is digital health technology and what can it do for me?
NIHRDiscover what research says about digital health technology, and how it can help manage our health. Take the quiz, what do you know about digital health tech?
Diversity & Dementia: how is research bridging the gap?
UK DRI webinar recording, featuring talks from leading researchers exploring diversity and dementia: how is research reducing health disparities
Forced Into Fat-Burning Mode, Microglia Gobble Up Plaques
Scientists led by Jie Zhang, Xiamen University, reported that hexokinase 2—a pivotal enzyme in glucose metabolism—ramps up in microglia in the AD brain.
The Lancet Neurology 20th Anniversary Lecture: Professor Carol Brayne CBE
The Lancet Neurology 20th Anniversary Lecture: “The relevance of social and commercial determinants for neurological health”.
Lecanemab Phase 3 Trial Meetings Primary Endpoint
Eisai confirms phase 3 Amyloid drug trial success with Clarity AD and sets sights on US, Euope and Japan approvals by March 2023